{
  "actions": [
    {
      "acted_at": "2003-06-09", 
      "references": [
        {
          "reference": "CR S7543-7544", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2003-06-09", 
      "committee": "Committee on Finance", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Finance.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s1206-108", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Finance", 
      "committee_id": "SSFI"
    }
  ], 
  "congress": "108", 
  "cosponsors": [
    {
      "district": null, 
      "name": "Roberts, Pat", 
      "sponsored_at": "2003-06-16", 
      "state": "KS", 
      "thomas_id": "00968", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2003-06-09", 
  "number": "1206", 
  "official_title": "A bill to amend title XVIII of the Social Security Act to provide for special treatment for certain drugs and biologicals under the prospective payment system for hospital outpatient department services under the medicare program.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Beneficiary Access to Care Act of 2003", 
  "sponsor": {
    "district": null, 
    "name": "Bond, Christopher S.", 
    "state": "MO", 
    "thomas_id": "01286", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2003-06-09", 
  "subjects": [
    "Ambulatory care", 
    "Cancer", 
    "Chemotherapy", 
    "Congress", 
    "Congressional investigations", 
    "Congressional reporting requirements", 
    "Drug therapy", 
    "Drugs", 
    "Economics and public finance", 
    "Federal budgets", 
    "Health", 
    "Hospital rates", 
    "Legislation", 
    "Medical fees", 
    "Medicare", 
    "Off-budget expenditures", 
    "Pharmacies", 
    "Prescription pricing", 
    "Social welfare"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2003-06-09", 
    "text": "Beneficiary Access to Care Act of 2003 - Amends title XVIII (Medicare) of the Social Security Act with respect to the prospective payment system for hospital outpatient department services (OPD) to: (1) require the Secretary of Health and Human Services to treat as a separate group of covered OPD services any drug or biological that was treated as such a group as of December 31, 2002, and any drug or biological that has ceased to be eligible for transitional, pass-through payments by reason of the limited period of payment specified; and (2) add special rules for 2004 for the calculation of Medicare OPD fee schedule amounts, among other payment-related changes.Directs the Comptroller General to study and report to Congress on pharmacy services used to provide cancer drug therapies in hospital outpatient setting."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Beneficiary Access to Care Act of 2003", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to amend title XVIII of the Social Security Act to provide for special treatment for certain drugs and biologicals under the prospective payment system for hospital outpatient department services under the medicare program.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:32:21-05:00"
}